Harvard stem cells

Highlights of Science Writers DC Stem Cell Panel with FDA’s Peter Marks

IMG_7988

I’m enjoying attending and speaking at the annual Science Writers 2018 meeting in D.C. where I spoke this morning on a panel about stem cells. The session was specifically on the Wild West of stem cells. You can follow the meeting events on Twitter with the #sciwri18 hashtag. I had three wonderful fellow panelists, Marilynn Marchione of …

Highlights of Science Writers DC Stem Cell Panel with FDA’s Peter Marks Read More »

ViaCyte & CRISPR Therapeutics team up to battle diabetes

ViaCyte

What happens when one of the most exciting stem cell biotechs ViaCyte teams up with a firm like CRISPR Therapeutics to use a combination of gene editing and cell therapy? Hopefully a synergistic partnership emerges that in this case can develop an effective stem cell-based therapy for diabetes. You can see a press release on …

ViaCyte & CRISPR Therapeutics team up to battle diabetes Read More »

Stem cells for Diabetes: the danger of the word ‘cure’

Stem-cell-Diabetes-Hype

There has been considerable discussion about the whether the media hyped the recent Harvard stem cells for diabetes paper (see top 10 takeaways of that paper). I believe that this was greatly hyped. This Harvard publication reported production of insulin-secreting cells from human embryonic stem cells (hESC). Newspapers around the world widely exaggerated the potential impact …

Stem cells for Diabetes: the danger of the word ‘cure’ Read More »

Takeaways From Harvard Stem Cells for Diabetes Paper

Harvard-stem-cells-Diabetes

The idea of using stem cells for treat Type I Diabetes is very promising and could have huge practical impact. Real progress has been achieved toward this goal over the last decade. In perhaps another decade there might be a validated treatment. A new stem cell paper has just come out in Cell from Harvard in this …

Takeaways From Harvard Stem Cells for Diabetes Paper Read More »